Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03188796Phase 3Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Role: collaborator

NCT04938713Not ApplicableUnknown

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome.

Role: lead

NCT01871753Phase 4Completed

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria

Role: collaborator

NCT03264417Completed

Pulmonary Function Test Study - Automated Interpretation

Role: collaborator

NCT03634904Not ApplicableUnknown

Serum Ceftazidime Concentrations in Hemodialysis Patients

Role: lead

All 5 trials loaded